CNBC's Dominic Chu reports activist investor Carl Icahn will now include Facebook as a forum to disclose information and communicate with investors.» Read More
Carl Icahn is gearing up for another fight, saying Monday that Transocean's dividend payment recommendation of $2.25 a share is "too little, too late."
CNBC's Scott Wapner reports the billionaire investor plans to put up a slate on the board of Transocean.
The picture that you can't ever unsee.
Herbalife is announcing it is increasing the size of its board. Discussing what this means for Ackman and Icahn, with Tim Ramey, D.A. Davidson & Co. senior research analyst.
Herbalife is announcing it is increasing the size of its board, reports CNBC's Josh Lipton.
CNBC's Robert Frank and Courtney Reagan discuss recent situations where business became personal: the Bill Ackman-Carl Icahn feud and the battle over Martha Stewart products between JC Penney and Macy's.
CNBC's Scott Wapner reports hedge fund manager Bill Ackman's first response to Herbalife's better than expected earnings.
CNBC's Scott Wapner reports the details of Herbalife's earnings data.
Herbalife is reporting quarterly earnings after today's closing bell. Tim Ramey, D.A. Davidson senior research analyst, offers insight on the stock's performance in the last year.
Billionaire investor Carl Icahn spoke with CNBC's Scott Wapner on "Fast Money Halftime Report," about his stake in Herbalife. Wapner and CNBC's Herb Greenberg, share their opinions.
CNBC's Scott Wapner offers insight on his conversation with billionaire investor Carl Icahn regarding his stake in Herbalife. CNBC's Herb Greenberg, provides perspective.
Carl Icahn tells "Fast Money Halftime" that his primary motivation is to make money with his Herbalife bet, but he won't feel sorry if Bill Ackman's short position gets squeezed.
In a live telephone interview on “Fast Money Halftime,” Carl Icahn says his primary motive for betting on Herbalife is to make money, but he won’t feel sorry if Bill Ackman loses along the way. (2:07)
The FMHR traders share their opinions on Carl Icahn's massive Herbalife position. Icahn is expected to speak with CNBC's Scott Wapner ahead.
Billionaire investor Carl Icahn says he only buys stocks he believes are undervalued, like Herbalife. He says Ackman's paper on Herbalife contains no expert opinion and the exposure has given him a great opportunity to buy. The interview is followed by a discussion with the FMHR traders.
In a live “Fast Money Halftime” telephone interview, activist investor Carl Icahn is asked why he’s bought a stake in Herbalife, directly challenging Bill Ackman’s high-profile short against the company. (3:11)
CNBC's Herb Greenberg weighs in on Icahn's belief that Herbalife's business model is solid and his decision to take a 13 percent stake in the company.
Carl Icahn now has a 13 percent stake in Herbalife. How great will Icahn's Herbalife gain be compared to Bill Ackman's Herbalife pain? Or will the tables turn? CNBC's David Faber, Carl Quintanilla and Melissa Lee discuss.
Discussing Carl Icahn's stake in Herbalife, and how he might trade the stock, with Ken Squire, 13D Management founder.
Shares of the nutritional-supplement company are down 20% since the hedge-fund managers duked it out on CNBC on Jan 25.